Osimertinib (Tagrisso) for adjuvant treatment of NSCLC.
Med Lett Drugs Ther
; 65(1682): e131-e132, 2023 08 07.
Article
in En
| MEDLINE
| ID: mdl-37516900
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Carcinoma, Non-Small-Cell Lung
/
Lung Neoplasms
Limits:
Humans
Language:
En
Journal:
Med Lett Drugs Ther
Year:
2023
Document type:
Article